Out of balance: the role of evolutionary mismatches in the sex disparity in autoimmune disease. by Keestra, Sarai M et al.
Medical Hypotheses 151 (2021) 110558
Available online 29 March 2021
0306-9877/© 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Out of balance: the role of evolutionary mismatches in the sex disparity in 
autoimmune disease 
Sarai M. Keestra a,b,*, Victoria Male c, Gul Deniz Salali d 
a Amsterdam UMC, University of Amsterdam, the Netherlands 
b Department of Global Health & Development, London School of Hygiene and Tropical Medicine, UK 
c Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, UK 
d Department of Anthropology, University College London, UK   







Pregnancy compensation hypothesis 
A B S T R A C T   
Over the past century autoimmune disease incidence has increased rapidly in (post-) industrialised, affluent 
societies, suggesting that changes in ecology and lifestyle are driving this development. Epidemiological studies 
show that (i) 80% of autoimmune disease patients are female, (ii) autoimmune diseases co-occur more often in 
women, and (iii) the incidence of some autoimmune diseases is increasing faster in women than in men. The 
female preponderance in autoimmunity is most pronounced between puberty and menopause, suggesting that 
diverging sex hormone levels during the reproductive years are implicated in autoimmune disease development. 
Using an evolutionary perspective, we build on the hypotheses that female immunity is cyclical in menstruating 
species and that natural selection shaped the female immune system to optimise the implantation and gestation 
of a semi-allogeneic foetus. We propose that cyclical immunomodulation and female immune tolerance mech-
anisms are currently out of balance because of a mismatch between the conditions under which they evolved and 
(post-)industrialised, affluent lifestyles. We suggest that current changes in autoimmune disease prevalence may 
be caused by increases in lifetime exposure to cyclical immunomodulation and ovarian hormone exposure, 
reduced immune challenges, increased reproductive lifespan, changed reproductive patterns, and enhanced 
positive energy balance associated with (post-)industrialised, affluent lifestyles. We discuss proximate mecha-
nisms by which oestrogen and progesterone influence tolerance induction and immunomodulation, and review 
the effect of the menstrual cycle, pregnancy, and contraceptive use on autoimmune disease incidence and 
symptoms.   
Introduction 
Over the past 150 years, life expectancy in (post-)industrialised, 
affluent societies has increased concurrently with advances in public 
health, medicine, nutrition, and sanitation [1]. Whilst incidence of in-
fectious diseases has consequently declined, the prevalence of degen-
erative and chronic diseases, detrimental to quality of life and long-term 
health, is increasing [2]. After cardiovascular disease and cancer, 
autoimmune diseases are now the most common disease category in the 
United States, with 5–8% of the population affected [3]. Autoimmune 
disorders are caused by an immune response erroneously launched 
against an individual’s own body because of the loss of immune non- 
reactivity, also known as immune tolerance, for self-antigens [4]. 
More than eighty autoimmune diseases have been identified and the 
worldwide prevalence is estimated at approximately 4.5% [5]. In recent 
decades autoimmune disease incidence has rapidly increased in (post-) 
industrialised, affluent societies, at rates of between 3.7 and 7.1% 
annually [6], suggesting that contemporary changes in our ecology 
ecolo and lifestyle are driving this trend. 
As the category of autoimmune disease encompasses a wide range of 
disorders, resulting from diverse aetiologies and affecting a variety of 
bodily systems, there are only few epidemiological studies that have 
aggregated autoimmune disease incidence. However, when looking at 
these reports it is striking that (i.) approximately four out of every five 
autoimmune disease patients is female [3,7], (ii.) the incidence of some 
inflammatory autoimmune diseases, most notably multiple sclerosis 
(MS), is increasing faster in females than males [8], and (iii.) the co- 
occurrence of several autoimmune diseases in one individual is more 
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common among women than men [9]. Furthermore, when comparing 
autoimmune diseases first presenting themselves in early adulthood to 
those with a childhood onset, an increase in the female propensity to 
develop autoimmune diseases can be noticed for some disorders 
following the pubertal transition (Fig. 1) [10,11], whilst an opposite 
shift in the sex disparity is seen following menopause when the female: 
male incidence gap narrows again for some but not all autoimmune 
diseases [10,12,13] (see Fig. 2). 
Evolutionary medicine suggests that the transition to life in an 
evolutionary novel environment associated with a(post-)industrialised, 
affluent lifestyle may have significant repercussions for psychological 
and physiological functioning as conditions in these contexts are 
fundamentally different from those in which we evolved, causing an 
evolutionary mismatch [14]. Making use of Tinbergen’s four questions 
in biology, covering both ultimate and proximate explanations for 
health and disease, evolutionary medicine allows for the integration of 
insights into the developmental plasticity and evolutionary significance 
of biological traits with the proximate molecular mechanisms under-
lying them [15–17]. Such an approach sheds new light on the biological 
paradox that women are on the one hand more likely to experience a 
breakdown of tolerance to specific self-antigens in autoimmune disease, 
whereas they must also be able to tolerate the presence of a semi- 
allogeneic foetus during nine months of gestation in order to reproduce 
successfully. Sir Peter Medawar, one of the pioneers of transplantation 
science, was the first to suggest that research into immunomodulation 
and tolerance during pregnancy may enhance our understanding of the 
tolerance mechanisms that also play a role in the development of 
autoimmune disease [18]. He suggested that in response to pregnancy, 
which he likened to the implantation of an allograft, mothers dampen 
down their immune responses indiscriminately to prevent immunolog-
ical rejection of the offspring. Although research has shown that preg-
nant mothers are not systemically immunosuppressed nor the foetus 
immunologically inert [19], understanding immunomodulation dur-
ing pregnancy may still offer novel insights into the propensity of 
women to develop autoimmune diseases during their lifetime more often 
than men. Explanatory Box 1 gives an overview of all proximate 
mechanisms that may predispose and trigger autoimmune disease in 
women and that have been previously proposed to underlie the sex 
disparity in autoimmune disease. 
We propose that increased lifetime exposure to reproductive hor-
mones and number of menstrual cycles might alter central and pe-
ripheral tolerance mechanisms and contribute to an increase in 
autoimmune disease incidence in women living in (post-) industrialised, 
affluent contexts. Natri et al. [20] have previously hypothesised that as a 
Fig. 1. Sex ratios in autoimmune diseases incidence during childhood versus those that are likely to appear during early adulthood, the reproductive years or after 
menopause. N.B. that some of the autoimmune diseases with childhood onset have an infectious aetiology. Interestingly autoimmune disorders that appear in early 
adulthood and more often occur in women, also more frequently co-occur with other autoimmune diseases. Comparing the last graph on the bottom left with the first 
graph on the top right, one can see that after menopause the sex disparity in autoimmune disease incidence is more similar to that seen before the onset of the 
reproductive years. Please note that in the publication by Beeson [10]a these graphs are based on, teenagers up to age 15 were counted as ‘children’. Considering that 
most girls undergo menarche before age 15, this might skew the graphs’ ability to demonstrate the influence of the reproductive transition itself on autoimmune 
incidence. The graphs are a visualisation of data taken from Beeson [10]; MS data from Chitnis [11]. 
S.M. Keestra et al.                                                                                                                                                                                                                              
Medical Hypotheses 151 (2021) 110558
3
result of natural selection on pregnancy and invasive placentation, 
evolved sex differences in gene content and dosage might contribute to 
sex-specific immune modulation and underlie the observed sexual 
dimorphism in autoimmune disease and cancer rates [20]. Alvergne and 
Högqvist Tabor [152] have additionally pointed out the cyclical nature 
of female health, and suggested that the effects of menstrual cycle on the 
immune function need to be considered when studying autoimmune 
disease from an evolutionary perspective. Building on these proposi-
tions, we hypothesise that cyclical immunomodulation through female 
sex hormones contributes to the observed sex disparity in autoimmune 
disease incidence and symptoms. Using an evolutionary ecology 
framework, we discuss the effect of ovarian steroids on the regulation of 
the adaptive immune system at different stages of female reproductive 
lifespan. We also discuss how recent alterations in reproductive pat-
terns, lifestyle, and the consequent increase in the lifetime exposure to 
ovarian steroid hormones, might have exacerbated the sex disparity in 
autoimmune disease in recent decades. We furthermore predict that 
when populations start adopting a (post-)industrialised, affluent lifestyle 
characterised by energetic affluence [21,22], the sex disparity in auto-
immune diseases may further increase. We specifically review the 
pathways by which sex hormones modulate lymphocyte development 
and differentiation during menstrual cycle and pregnancy, discussing 
the role of puberty and menopause in sex difference in autoimmune 
disease incidence. By doing so we provide evidence for the hypothesis 
that reproductive hormone levels shape autoimmune disease incidence 
and symptoms during a female’s reproductive lifespan by modulating 
tolerance mechanisms and immunoregulation during the menstrual 
cycle and pregnancy. Finally, we highlight some relevant findings 
regarding the influence of ecological pressures on ovarian hormones in 
women, based on which we suggest new avenues for autoimmune dis-
ease research. 
Evolutionary mismatches and the prevalence of autoimmune 
disorders 
We propose that the observed increase in autoimmune disease 
prevalence and patterns might be caused by a mismatch between the 
ecological conditions in which immune tolerance and cyclical immu-
nomodulation mechanisms originally evolved in and modern (post-) 
industrialised, affluent lifestyles (Fig. 3). Here, we summarise these 
mismatches, which may lead to higher lifetime exposure to ovarian 
steroids and cyclical immunomodulation and may contribute to the 
observed increased incidence in autoimmune diseases amongst women 
in (post-)industrialised, affluent contexts, focussing on: 1) increased 
reproductive lifespan, 2) changing reproductive patterns, 3) fewer im-
mune challenges, 4) positive energy balance. 
Increased reproductive lifespan 
Currently, girls living in (post-)industrialised, affluent environments 
often undergo menarche earlier than previous generations [23,24], and 
are therefore exposed to the cyclical changes in tolerance and immu-
nomodulation for a longer period of time. In (post-)industrial, affluent 
contexts, age of first menstruation has declined dramatically over the 
past two centuries concurrent with improved quality of early life envi-
ronments and decreases in infant mortality rates [25]. This, along with a 
potential upward secular trend in age of menopause, has increased fe-
male reproductive lifespan [26]. Girls that undergo menarche before age 
Fig. 2. An overview of the different proximate mechanisms that have been proposed to explain the difference in autoimmune prevalence between men and women. 
We have reorganised these proximate explanations to reflect the distinction between predisposing and triggering factors for autoimmunity. In red are factors that are 
directly related to female reproductive functioning. Drawing inspired by Quintero et al. [155], Anaya [9], and Rubtsova et al. [156]. 
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twelve may also experience higher serum oestradiol levels during their 
menstrual cycles [27]. Longer lifetime exposure to ovarian cyclicity and 
its associated hormones can impact autoimmune disease development as 
research has suggested that earlier age of menarche causes multiple 
sclerosis (MS) symptoms to occur earlier and be more severe 
[11,28,29]. 
Changing reproductive patterns 
In comparison to the contemporary natural fertility populations as a 
Explanatory Box 1 
An overview of proximate mechanisms that may contribute to the sex disparity in autoimmunity 
A wide range of molecular mechanisms have been identified that may contribute to a higher autoimmune disease prevalence in women than in 
men, which can be subdivided in both predisposing and triggering factors (Figure 2). Whereas predisposing factors contribute to the devel-
opment of immune cells that aberrantly recognise self-antigens as foreign in the first place, trigger factors may cause the subsequent activation of 
these autoreactive immune cells. For example, skewed X-chromosome activation in women may cause autoreactive T-cells for certain X- 
linked genes escape tolerance induction processes during thymic development [155], whereas differential exposure to environmental-, dietary-, 
social-, and stress-related factors, may subsequently play a role in triggering autoimmune disease [17,156]. Several predisposing and triggering 
factors also directly relate to female reproductive functioning. For example, the bidirectional exchange of cells during pregnancy may predispose 
women to develop autoimmunity following pregnancy when immune responses are launched to remove foreign foetal cells (microchimerisms) 
from the body [157,158], whilst men and women also display different immune profiles during the reproductive years under the influence of 
pregnancy and sex hormones more generally. Research has furthermore shown that women exhibit stronger humoral and cellular immune 
responses than men as the ‘female’ sex hormones oestrogen and progesterone favour the survival of the adaptive immune system’s B-cells and 
T-helper- (Th) cells [11,54,145,146]. Using an evolutionary medicine approach, we evaluate the effects of the ovarian steroids oestrogen and 
progesterone on the adaptive immune system’s tolerance mechanisms in particular, describing pathways by which sex hormones influence the 
development and symptoms of autoimmune disease in women during the reproductive years.  
Fig. 3. The Out of Balance Hypothesis. This figure outlines various factors that can increase our lifetime exposure to ovarian steroid hormones and cyclical 
immunomodulation. Although originally increases in lifetime oestrogen exposure have been implicated in the development of reproductive cancers, we propose that 
high lifetime exposure to ovarian steroid hormones, especially oestrogen, can also have a profound impact on the immune system and subsequent autoimmune 
disease development. This figure uses information from the following sources: Jasienska [62], p. 15, Natri et al. [20] and Núñez-de la Mora and Bentley [135]. 
S.M. Keestra et al.                                                                                                                                                                                                                              
Medical Hypotheses 151 (2021) 110558
5
reference point for the female reproductive patterns for most of human 
evolution, women in (post-) industrialised societies spend a longer 
period cycling before first pregnancy, have fewer children, and spend 
less time breastfeeding [30]. Compared to modern-day foraging pop-
ulations, the mean age of menarche in (post-)industrialised, affluent 
context is nearly four years earlier, and affluent women in the United 
States spend approximately twelve years cycling before having a first 
child, compared to only three years in contemporary hunter-gatherer 
populations [30]. Whereas women from subsistence populations 
breastfeed for approximately 17 years over their reproductive lifespan, 
the total years of lactation in American women is only 0.5 [30]. Indeed, 
research among Dogon women in Mali suggests that women in natural 
fertility populations only cycle regularly if they are infertilei, with fertile 
females experiencing about 100 menstrual cycles over their lifetime 
compared to more than 300–400 hundred in women living in (post-) 
industrialised, affluent contexts in the United States [31]. Women are 
exposed to sharp increases and decreases of regulatory lymphocytes 
during each menstrual cycle [32], which means that delayed pregnancy 
and associated Treg increases in combination with reduced parity could 
maintain the immune system in a pro-inflammatory state for longer 
periods of time Natri et al. [20]. As predicted then, delayed pregnancy 
and nulliparity are a risk factor for developing inflammatory autoim-
mune diseases such as MS [33] and rheumatoid arthritis (RA) [34]. 
Further research in diverse reproductive ecologies is needed to investi-
gate how the number of menstrual cycles over a woman’s lifetime affects 
overall Treg-pool and peripheral tolerance. 
Fewer immune challenges 
Peripheral tolerance can be influenced by changes in microbial 
exposure, which also affects reproductive ecologye and thereby ovarian 
steroid levels. Proponents of the hygiene hypothesis, recently renamed 
as the “Old Friends Hypothesis”, have suggested that the transition to 
modern urban lifestyles depletes populations in (post-)industrialised, 
affluent contexts of the environmental input from co-evolved microbial 
organisms during early development, as a result of which their immune 
systems have become deregulated [35–38]. Pathogen exposure can also 
lead to more anovulatory cycles and oestrogen dysregulation [39], but 
in sanitised urban environment this occurs less frequently. Additionally 
a decrease in early life immune stressors may alter timing of maturation 
and menopause as well as ovarian hormone levels during the repro-
ductive lifespan [40]. For example, Bangladeshi women that came to the 
U.K. as childrenchi have been observed to have an earlier age of 
menarche and higher progesterone levels than women who remained in 
Bangladesh [41], which Nuñez-de la Mora and collaborators have sug-
gested to potentially be the result of fewer immune challenges during 
development and better sanitation and health care access in London 
compared to Sylhet. 
Positive energy balance 
Positive energy balance and increased adiposity associated with a 
(post-) industrialised, affluent lifestyle can also have distinct effects on 
the immune system, ovarian steroid levels, and reproductive lifespan. 
Adiposity increases the bioavailability of sex steroids in the blood [42] 
and enhances the local oestrogen production in adipose tissue [43]. A 
sedentary lifestyle with reduced physical activity is associated with 
higher oestradiol levels during the menstrual cycle of women of repro-
ductive age, thereby contributing to a higher lifetime cumulative 
exposure of this hormone [44]. Obesity might also cause a subclinical 
chronic inflammatory state, exacerbating autoreactive Th1/Th17 ef-
fects and favouring the differentiation of Th cells into Th17 cells instead 
of Tregs [45,46]. Leptin, a key adipokine which is twice as high in 
women than in men, also promotes the Th1 differentiation and inhibits 
Treg proliferation, thereby affecting peripheral tolerance [47]. Some 
studies have additionally found that a combination of low birth weight, 
early menarche, and excess weight in adulthood also leads to elevated 
oestradiol levels measured over a single menstrual cycle [48,49]. 
Although there is some research on the correlation between obesity and 
autoimmunity [47], no study has addressed the potential combinatory 
effect of obesity and hormonal changes occurring during reproductive 
transitions on peripheral tolerance. For example, it could be that the 
combined effects of excess adiposity and ovarian steroid exposure may 
contribute to increasing sex disparities in autoimmune disease incidence 
starting with puberty. As predicted, women that experienced childhood 
obesity, early menarche, and overweight in adulthood are at higher risk 
for developing certain inflammatory, Th1/Th17 mediated autoimmune 
diseases, such as MS [8,29]. Understanding the combined effect of 
excess adiposity during menopause might especially be relevant because 
of the existence higher total and unopposed oestrogen levels during 
this reproductive transition [50,51] and reduced peripheral tolerance 
due to the ageing of the immune system [52]. 
Below we explore the current state of the evidence that underlies 
these predictions and may strengthen our proposition that the observed 
increase in autoimmune disease prevalence and changing incidence 
patterns might be caused by a mismatch in immune tolerance and 
cyclical immunomodulation mechanisms. 
Proximate mechanisms by which ovarian steroids influence 
tolerance and cyclical immunomodulation 
Various steps during the normal development and maturation of 
adaptive immune cells prevent the development of autoimmunity by 
inducing immune tolerance to healthy bodily tissues through deleting 
or neutralising autoreactive immune cells [53]. These mechanisms can 
be subdivided in central and peripheral tolerance depending on 
whether they take place during the early development of the adaptive 
immune cell in the thymus or only after they have been released into the 
circulation. Whereas reduced central tolerance may cause autoreactive 
lymphocytes to escape stringent selection processes during development 
and enter the circulation, reduced peripheral tolerance can cause the 
subsequent activation of these autoreactive cells. As we will describe, 
oestrogen and progesterone can influence both central and peripheral 
tolerance, thereby influencing autoimmune disease risk, and affecting 
immunomodulation, specifically balances between T regulatory and 
Th17 cells. In Explanatory Box 2 we offer an overview of the adaptive 
immune system and associated cytokines and explain the difference 
between humoral and cellular arm of the immune response, which is 
essential for understanding predictions regarding changes in patterns in 
autoimmune disease incidence. 
Immune tolerance during reproductive transitions: the role of 
AIRE 
During development in the thymus, T cells undergo a complex 
negative selection process in which T cells with too high affinity for self- 
antigens are deleted, whereas those with weak interactions develop into 
normal T cells (Fig. 5a) [54,55]. Those with an intermediate autor-
eactivity are positively selected to form long-lived population of native 
Tregs harbouring the ability to suppress other immune cells 
[53,54,56–58]. Central tolerance induction is enabled by the tran-
scription of the autoimmune regulator (AIRE), which stimulates med-
ullary thymic epithelial cells (mTECs) to express tissue-specific self- 
antigens (TSA) from various places around the body, allowing the 
training of immature T cells [53,59]. Genetic deficiencies or defects in 
AIRE transcription factor makes the carriers more likely to have multi-
ple, co-occurring autoimmune diseases, and autoreactive T cells and 
autoantibodies [59]. 
Oestradiol, the main oestrogen hormone during the menstrual cycle, 
may influence the process of central tolerance induction via AIRE [54]. 
Due to the involvement of T-follicular-helper cells in their maturation, B 
cell tolerance is thereby affected as well [59,60]. In healthy individuals, 
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Explanatory Box 2 
Cellular and humoral immunity and associated T-helper cells and cytokines 
Autoimmune diseases can broadly be classified as originating from the humoral arm of the adaptive immune response, encompassing B cells 
and antibodies, or as being mediated by cellular immunity, comprising immune cells such as cytotoxic T cells and macrophages [71,159] (Fig. 4 
& Table 1 [4,7,69,98,107,117,160–164]). This classification is based on the way that different types of cytokines mediate the differentiation of 
T-helper (Th) cells into different types which coordinate the healthy immune response [122,165]. Cytokines enable cross-communication and 
coordination between innate and adaptive immune responses [166], which is how the immune system is able to effectively eliminate unwanted 
intruders. Anti-inflammatory cytokines promote Th2 differentiation and are responsible for activating the humoral immune system vital for 
protection against extracellular parasites [71,167]. Cellular immune responses, facilitated by Th1 and Th17 cells, are important for the 
eradication of cells infected by intracellular pathogens and viruses and are activated by pro-inflammatory cytokines (71,159). Finally, spe-
cialised T regulatory cells (Tregs) supervise the functions of effector Th cells by suppressing immune responses, playing a key role in auto-
immunity [166,168].  
Fig. 4. An overview of the human adaptive immune system and its associated cytokines. The adaptive immune system can roughly be subdivided into humoral and 
cellular responses, which are mediated by Th2 or Th17 and Th1 cells respectively. Tregs supervise the activities of the different immune responses and play an 
important role in the regulation of the immune system. Illustration drawn based on [164,168,169, b0170 b0165,171]. 
Table 1 
Cytokines and their effects. Immune cells secrete various cytokines with different functions, which have either stimulatory or inhibitory effects on the cellular or 
humoral arms of the immune system. Tregs suppress and control the different responses and are important in the maintenance of peripheral tolerance.  
Cell of origin Cytokines Stimulate Inhibit Function 
Th1 IFNγ Th1, macrophages Th2, Th17 Intracellular pathogens 
Macro- phages IL-1, IL-6, IL-12, IL-18, IFNα, IFNγ Inflammation, fever, acute phase response, plasma cell formation  N/A 
Th17 IL-22, IL17 Neutrophils, antimicrobial peptide-production Th1, Th2 Extracellular bacteria, fungi 
Treg TGFβ, IL10 Tregs  Suppression/     
Tolerance 
Th2 IL-4, IL-5, IL-13 Th2, B cells Th1, Th17 Extracellular parasites  
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AIRE expression is epigenetically down-regulated by oestradiol but up- 
regulated by the androgen dihydrotestosterone (DHT) [54]. As a 
consequence, females express less AIRE in their mTECs during the 
reproductive period, causing differences in central tolerance after the 
hormonal sexual dimorphism of the pubertal transition [54,61]. As AIRE 
is important in preventing autoimmunity, we would predict that under 
the influence of increases in oestradiol, women will be more likely to 
develop an autoimmune disease than men and to suffer from co- 
occurring autoimmune diseases. An increase in lifetime ovarian ste-
roid exposure as predicted by our hypothesis might affect mechanisms of 
central tolerance induction through oestrogen-mediated down-
regulation of AIRE expression in the thymus, as a result of which 
negative selection of autoreactive immune cells is reduced under a 
threshold that makes women more susceptible for autoimmunity and 
developing co-occurring autoimmune diseases [54,62]. 
Tolerance during the menstrual cycle: the role of inflammation 
If autoreactive lymphocytes escape the stringent selection processes 
during development and start circulating around the body, specialised 
Tregs and B regulatory cells are usually still able to suppress them 
[54,63] (Fig. 5b). In absence of necessary co-stimulatory ‘danger’ mol-
ecules autoreactive lymphocytes are neutralised, and under the influ-
ence of cytokine TGF-β autoreactive T cells can even be induced to 
become Tregs themselves [64–66]. Yet they are less stable in their 
function than thymus-derived Tregs because of their shared differenti-
ation pathway via TGF-β with Th17 cells, which play an important role 
in cell-mediated autoimmune disease (see Fig. 5). A pro-inflammatory 
environment favours Th17 differentiation of these lymphocytes and can 
thereby alter the balance between Tregs and Th17 cells [60,67]. 
Ovarian hormone changes may influence peripheral tolerance by 
contributing to increases in systemic inflammation, as measured using 
CRP-levels in the blood [68], at certain points in the menstrual cycle 
(Fig. 6). Oestrogen, especially oestradiol, has a dose-dependent effect on 
the proliferation of certain types of Th cells during the menstrual cycle, 
with low doses in the follicular phase favouring cellular immunity and 
Th1 and Th17 cell proliferation, whilst high levels around ovulation 
promote humoral immune responses mediated by Th2 cells [69,70]. 
During the luteal phase, progesterone additionally induces Th2 cyto-
kine production [71,72], away from the pro-inflammatory cytokines 
that favour Th17 differentiation over Tregs. Additionally, oestradiol 
stimulates expansion of Tregs during the luteal phase, which might be 
important for successful implantation of an embryo during this time 
[32]. Thus, whereas an inflammatory environment and stronger Th1/ 
Th17 responses characterise the follicular phase, Th2/Treg levels seem 
to be elevated during the luteal period of the menstrual cycle. Combined 
with the effects of the ovarian steroids on cytokine production 
depending on menstrual cycle phase, one would expect ovarian steroid 
levels to affect autoimmune disease symptoms by changing the balance 
between cellular and humoral immune responses. 
Tolerance during pregnancy: the importance of Th cell balances 
Similar to the luteal phase of the menstrual cycle, pregnancy is 
characterised by an anti-inflammatory Th2/Treg immune profile. Dur-
ing early pregnancy, the progesterone increase stimulates the preferred 
differentiation of naïve T-helper cells into humoral immunity promot-
ing Th2 cells [73], whereas at the same time hCG and oestrogen induce 
Treg expansion at the implantation site and in the blood [74–77]. 
Research suggests that appropriate Th1/Th2 and Th17/Treg balances 
might be important for successful gestation of a semi-allogeneic foetus, 
as the peripheral blood and decidua of women with unexplained 
recurrent spontaneous abortion have a reduced Treg proportion 
compared to Th17 cells [78]. In women with preeclampsia, another 
disorder of pregnancy, Treg and Th2 cell numbers are declined in the 
umbilical cord blood [79]. Elevated Th1 and Th17 percentages, higher 
inflammatory cytokine ratios, and decreased Treg percentages in early 
pregnancy are in contrast associated with developing preeclampsia later 
in pregnancy [80]. Although further research is necessary to verify 
whether women with a strong innate pro-inflammatory cytokine profile 
before pregnancy are more likely to develop preeclampsia later on, the 
optimal balance between Th cells as well as pro- and anti-inflammatory 
Fig. 5. Sex hormones influence central and peripheral tolerance induction. 5a (left): central tolerance induction in the thymus. Oestradiol causes the downregulation 
of the Autoimmune Regulator (AIRE) gene in mTECs, decreasing the expression of TSAs. This consequently decreases central tolerance induction during T cell 
development, and might contribute to sexual dimorphism in autoimmune disease incidence. 5b: peripheral tolerance induction. The ovarian hormone fluctuations of 
the menstrual cycle influence systemic inflammation levels. An inflammatory environment favours Th17 differentiation over the induction of Tregs and might 
therefore alter the delicate balance between Th17 and Treg cells. 
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immune responses might be important for successful gestation. The 
expansion of Tregs suppressing cellular responses against the semi- 
allogeneic offspring, might at the same time enhance the peripheral 
suppression of autoreactive immune cells during gestation [81]. Com-
bined with the shift towards a Th2, anti-inflammatory immune profile, 
this would predict that during pregnancy the symptoms of autoimmune 
disease patients might improve for those suffering from cell-mediated, 
inflammatory autoimmune disease such as RA or MS, whereas those 
with an antibody mediated, humoral autoimmune disease disease 
would experience exacerbations of their symptoms. 
Reproductive hormone levels influence autoimmune disease 
symptoms and incidence 
Hormonal changes during the menstrual cycle influence the symp-
toms of women with autoimmune diseases. In some women suffering 
from the relapsing-remitting form of MS, an inflammatory, cell-medi-
ated autoimmune disease of the nervous system, symptoms ameliorate 
during the luteal phase in which cellular immunity is more suppressed, 
but worsen again during the premenstrual decline in sex hormone levels 
[82–84]. This cyclical effect seems however to be limited to a subgroup 
MS patients [83,84]. On the opposite side of the autoimmune disease 
spectrum, the surge in anti-inflammatory cytokines and the stimulation 
of the Th2 cells during the luteal phase affect patients suffering from 
humoral autoimmune disease differently [69,85]. Women with sys-
temic lupus erythematosus (SLE), a humoral autoimmune disease 
caused by autoantibody production towards various organ systems, 
experience an exacerbation during the luteal phase of the menstrual 
cycle when Th2 responses dominate, with 80% of symptomatic flares 
occurring during this period [86]. The complex dynamics by which 
reproductive hormone changes associated with the menstrual cycle in-
fluence the symptoms of autoimmune diseases warrant further investi-
gation, also to understand why these effects occur only in a subset of 
patients. 
As predicted based on this review of the role of ovarian steroids on 
immunomodulation, the increase in anti-inflammatory cytokines and 
a Th2/Treg immune profile during gestation pregnancy has an 
ameliorating effect on the symptoms of RA, a cell-mediated autoim-
mune disease. Marked disease remission in up to 75% of pregnant pa-
tients with active RA, often to such an extent that medication can be 
drastically reduced [17,87,88]. This was already reported in the scien-
tific literature as early as 1938 [88]. However, postpartum, when oes-
trogen and progesterone concentrations fall, 90% of these patients 
experience a revival in disease activity concurrent with a shift back to a 
stronger cellular response [70,89,90]. In contrast, women with Graves 
autoimmune thyroiditis, a humoral autoimmune disease mediated by 
TSH-receptor auto-antibodies [91,92], experience a worsening of their 
disease early in pregnancy, but have their symptoms improve again later 
on, probably due to the positive effects associated with Treg increases 
[93,94]. 
Acknowledging the importance of these observations, biomedical 
research has long focused on finding potential treatments for alleviating 
the symptoms of autoimmune diseases using exogenous hormone 
administration, especially testing the benefits of oestradiolin mouse 
models of MS. For this disorder, oestradiol administration has been 
shown to decrease disease severity and even delay disease-onset 
[95,96]. Similarly, a case-control study in humans found MS incidence 
to be 40% lower in women who took hormonal contraception in the last 
three years, suggesting that high exogenous oestrogen levels may even 
delay the incidence of the first clinical attack of this cell-mediated in-
flammatory autoimmune disease [95,97]. However, on the other end of 
the spectrum, studies suggest that exogenous hormone administration 
might increase the incidence of developing humoral autoimmune dis-
ease such as SLE, with combined oral contraceptive starters being at a 
heightened risk [98,99]. The risk of developing SLE increases with 
greater concentrations of ethinyloestradiol in the pill formulation and is 
higher in women using first- or second-generation contraceptives that 
are known to have higher oestrogen doses compared to more modern 
drug formulations [99,100]. As predicted by our hypothesis, post-
menopausal exogenous oestrogen use also increases women’s SLE risk, 
and randomized, double-blind controlled trial of hormone replacement 
therapy in SLE patients slightly increases the risk of mild to moderate 
flares [101–103]. Oestrogen levels therefore influence not only symp-
toms of autoimmune disease, but might also be a contributing factor to 
autoimmune disease incidence, possibly by affecting central and pe-
ripheral tolerance induction mechanisms. 
Changes in endogenous sex hormone levels during the reproductive 
transition of puberty may also increase the incidence of autoimmune 
disease in women, shifting the sex ratio towards female preponderance. 
A Finnish cohort study found that girls during childhood are not more 
likely to present with type 1 diabetes T1D than boys overall [104], yet 
at age thirteen 87.5% of newly diagnosed T1D patients in the same 
cohort was female, coinciding with the age of menarche in the country 
[105]. Generally considered to be a childhood onset disease, T1D 
actually peaks at several points during the lifespan - during childhood 
(ages of 5–7), around puberty, and in the fifth decade around menopause 
Fig. 6. Human cyclical immunity. This figure represents the ovarian cycle, 
which can be subdivided in the follicular and the luteal phase. It shows the 
developing egg, ovulation, the corpus luteum, and its degeneration, and con-
current changes in ovarian and pituitary hormone levels. The third panel de-
picts the uterine menstrual cycle and its phases, including the growth and 
decline of the uterine lining. Finally, the lower panel shows how the ovarian 
cycle may influence cell-mediated and humoral immunity. The arrows highlight 
some inflammatory occurences in the menstrual cycle during the humoral 
mediated phase, which are (i.) the inflammatory process at ovulation just after 
the egg is released and (ii.) the inflammatory processes involved in decidual 
differentiation at the start of the reproductive window (days 20–23). Low 
oestrogen levels during the follicular phase favour Th1/Th17 differentiation, 
whereas in the luteal phase high progesterone and oestrogen promotes Th2 
responses. Consequently symptoms of cellular-mediated autoimmune diseases 
ameliorate during the luteal phase in most women whereas those of humoral 
autoimmune diseases worsen during this period. This figure was inspired by 
Alvergne & Tabor [85]. 
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- suggesting a role for shifting sex hormone levels during reproductive 
transitions in triggering autoimmunity [106,107]. Even in autoimmune 
diseases that are predominantly female, changing oestrogen levels 
associated with reproductive transitions may widen the incidence gap 
between women and men. For example, before puberty SLE already 
affects 3–4 girls for every boy, but during the childbearing years the 
incidence gap increases to as much as 9–20 females for every male 
[85,108,109]. A Chinese study furthermore found that although during 
the reproductive period SLE incidence was 13.3(f):1(m), the sex 
disparity in late onset, post-menopausal SLE was only 3.2(f):1(m) [110], 
which is remarkably similar to pre-pubertal numbers. Similarly, the sex 
ratio of RA, a cell-mediated autoimmune disease characterised by 
chronic inflammation of bone and cartilage [69], is 6(f):1(m) during the 
childbearing years but approaches 1(f):1(m) again for older ages of 
onset [111,112]. These epidemiological studies suggest that concur-
rently with the sexual dimorphism of reproductive hormone levels 
during the childbearing years, a change in autoimmune disease inci-
dence takes place, and that changes in endogenous levels of ovarian 
steroids might affect autoimmune disease incidence. 
Evolutionary perspectives on the sex disparity in autoimmune 
disease 
What can an evolutionary perspective bring to research on the in-
fluence of sex hormones on autoimmune disease incidence and symp-
toms? An evolutionary perspective acknowledges that our bodies are 
“bundles of compromises” shaped by natural selection with the ultimate 
purpose of reproducing and passing down our genes to subsequent 
generations [62,113,114]. Natural selection consequently preferentially 
acts on traits conferring an adaptive advantage before or during the 
childbearing years. As a consequence traits that are detrimental to 
health in post-reproductive life, including those contributing to 
increased autoimmunity, will still be inherited if they confer an 
advantage during reproduction or early survival [62,115–119]. There-
fore, the regulatory effect of ovarian steroids on central and peripheral 
tolerance induction in women might have evolved to ensure immune 
non-reactivity to paternal antigens displayed by the placenta during 
pregnancy to optimise reproductive success [20], yet these interactions 
might become deregulated in post-reproductive life. Accordingly, the 
evolution of placentation in mammals may have led to sex-specific se-
lection on immune function to induce tolerance to semi-allogeneic foetal 
antigens while still combating pathogens in pregnant mothers [20]. This 
could have left women at increased risk for autoimmune disease 
compared to men. Similarly, it has been suggested that a strong in-
flammatory response may be beneficial to survival in early life, whereas 
it might be detrimental to health in old age when Treg populations have 
declined, and chronic inflammation is associated with incidence of Th1/ 
Th17 mediated autoimmune diseases such as RA [120,121]. 
Secondly, life history theory, a branch of evolutionary biology, 
predicts that organisms optimise fitness in interaction with environ-
mental conditions through energy trade-offs between growth, repro-
duction, and somatic maintenance, including immunity, both over their 
own lifespan and across generations [85,122]. The observed variation in 
immune profile in women during the reproductive period suggests the 
existence of such a trade-off between reproduction and somatic main-
tenance. Following the importance of an anti-inflammatory Th2/Treg 
response during pregnancy, it has been previously hypothesised that 
women with innate cytokine profiles promoting Th2/Treg responses 
have a selectional advantage based on their enhanced ability to conceive 
[123,124], whereas women with elevated Th1 cell levels compared to 
Th2 responses are more likely to be subfertile [123,124] and at higher 
risk of implantation failure during IVF-treatment [125]. This is because 
women with strong Treg responses have a more tolerant response to the 
implantation of a semi-allogeneic embryo [126], and by increasing 
antibody production during pregnancy, the mother can provide her 
offspring with short-term passive immunity whilst the foetus’ own 
adaptive immune system develops [127]. This shift to humoral re-
sponses during pregnancy preferentially enhances the production of 
IgG-antibodies, which is a type of antibody unique to mammals [128] 
and the only maternal immune factors capable of crossing the placental 
barrier to the offspring [127]. However women with such a Th2/Treg 
profile might however be more susceptible to certain pathogens because 
of the inhibitory effect of anti-inflammatory cytokines on Th1 re-
sponses, suggesting a trade-off between reproduction and survival 
[123,124]. 
Thirdly, considering the importance of immune profile for maternal 
tolerance as well as pathogen defence and subsequent autoimmune 
disease risk, more research is needed on autoimmune disease incidence 
in different (pathogen) ecologies to understand the wide-reaching con-
sequences of these trade-offs between immunity and reproduction. 
Although research on immune function under different subsistence 
ecologies is limited, studies looking at Tsimane horticulturalists in 
Bolivia revealed that the infection with some helminths, such as 
roundworm which elicit a Th2 immune response, decreases age of first 
birth [129]. Yet, infection with some other parasites and receiving 
anthelminthic medications are associated with a lower chance of 
conceiving [129]. Because of a complex pathogen environment, Tsi-
mane experience elevated immunological parameters associated with 
inflammation compared to (post-) industrialised, affluent populations 
[130], but not higher autoimmune disease incidence [131]. This is 
possibly because the higher rate of helminthic infections induce Th2/ 
Treg responses, that regulate excessive inflammation [130]. As a first 
study of its kind, Hové et al. (2020) additionally investigated differences 
in changes in immune function between Tsimane and American women 
during pregnancy [132]. Tsimane females were found comparatively 
have higher lymphocyte (Th1) as well as eosinophil (Th2) counts than 
pregnant women in the United States, but experience lower levels of 
inflammation in later pregnancy. The authors suggest that continuous 
exposure to pathogens , which can also cause miscarriages, may influ-
ence the dynamicity of immunomodulation and tolerance during preg-
nancy in the Tsimane ecology. Investigating the complexity of pathogen 
ecology in relation to immunomodulation is necessary to enhance our 
understanding of interactions between women’s immune profiles and 
fertility, as these trade-offs may in turn affect autoimmune disease risk. 
Finally, an evolutionary medicine perspective highlights the impor-
tance of investigating the effect of recent changes in the ecology under 
which the interactions between the reproductive and immune system 
originally evolved, which can be considered a ‘mismatch’. Using the 
concept of WEIRD (Western, Industrialised, Rich, and Democratic) 
taken from the field of psychology [21], evolutionary anthropologists 
have argued that conventional biomedical research currently too 
heavily relies on participants of European descent living in urban, 
industrialised contexts, which are not representative of the lifestyle and 
ecological pressures experienced by our ancestors [133]. Most 
biomedical research on autoimmune diseases and sex hormones origi-
nates from (post-) industrialised, affluent societies that have adopted a 
Western lifestyle, which is not reflective of the energetic conditions 
during most of human evolution. Current immunological studies 
consequently fail to appreciate the existence of substantial variations in 
reproductive hormone levels between populations, members of the same 
group, and even between different cycles of the same woman [134]. 
Gene polymorphisms only partially account for these differences, which 
are instead the result of variations in age, ecology, and energetic factors 
that affect metabolic energy availability and their reallocation to vital 
functions other than reproduction [62,135]. Hormones are key modu-
lators in the optimal investment of energy into these competing physi-
ological functions and influence the timing of life-history events, such as 
the pubertal transition and menopause [136,137]. They are the mech-
anism by which organisms adapt cellular functions across different tis-
sues in response to endogenous and exogenous environmental factors 
[138]. Therefore, gonadal function is sensitive to ecological influences, 
such as immune challenges, nutrition, and energy expenditure 
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[139,140]. Additionally, conditions during early development create set 
points for the regulation of the reproductive axis in adulthood leading to 
differences between populations as well [62,139,141]. It is for these 
reasons that ecological changes which are able to alter endogenous 
hormone levels, thereby potentially increasing the risk of autoimmune 
disease,deserve much more attention in biomedical research. 
What about testosterone and men? 
In this paper we have mainly focused on the effect of the ‘female’ sex 
hormones on the adaptive immune system, neglecting the role of the 
testosterone in central and peripheral tolerance induction and immu-
nomodulation. Similarly to women, men who transition towards a 
Westernised, (post-) industrialised, affluent lifestyle also experience 
higher sex steroid levels. For example, Bangladeshi men who migrated 
to London, UK, in early childhood experience higher testosterone levels 
than their counterparts that remained in the rural parts of Bangladesh 
[144]. Thus we predict that whilst increases in oestrogen and proges-
terone may put women at an increased risk of developing autoimmune 
diseases, an opposite trend may be taking place in regard to men and 
testosterone. Although discussing the full implications of this research is 
beyond the scope of this paper, the influence of changing testosterone 
levels following the adoption of a modern Westernised, (post-)indus-
trialised, affluent lifestyle should also be investigated in the context of 
autoimmune disease in men. 
Although androgens such as testosterone promote cytotoxic T cell 
proliferation, compared to women men display lower humoral and 
cellular immune activity, which are the arms of the adaptive immune 
system involved in the development of autoimmunity [11,54,145,146]. 
AIRE expression, which is implicated in central tolerance, is epigeneti-
cally up-regulated by the androgen dihydrotestosterone, as a conse-
quence of which males express more AIRE in their mTECs than females 
during the reproductive period [25,55]. This may cause a difference in 
central tolerance after the hormonal sexual dimorphism occurs. Addi-
tionally, testosterone may play an important role in autoimmune disease 
progression and symptoms. In a study of MS patients, women with the 
lowest testosterone levels as well as men with the highest oestradiol 
levels experienced more brain lesions [89]. Furthermore, in obese men 
there is an even more distinct increase in plasma oestrogen levels 
compared to women [147], altering relative testosterone to oestrogen 
ratio’s due to excess adiposity. In this context, there is a dearth of studies 
focussing on the importance of relative hormone ratio’s rather than 
absolute hormone levels on autoimmune disease risk, whereas for car-
diovascular diseases research seems to suggest that determining relative 
testosterone to oestrogen ratio’s may be a more valuable predictor than 
looking at either hormone in isolation [148]. Finally, despite an abun-
dance of studies suggesting that hormonal changes over the life span 
affect autoimmune disease risk in women, no such research has been 
conducted in men, despite a documented age-related drop in the pro-
duction of testosterone and other androgens during andropause, whilst 
oestrogen levels remain similar [149,150]. 
Conclusion and future directions 
Of all immunology articles, less than 10% considers the sex of the 
participants in their analysis [151] and this bias persists in animal model 
studies [152]. Although compared to other areas of biomedicine auto-
immune disease research has already acknowledged that taking sex and 
parity into consideration is key to understanding the female prepon-
derance in autoimmunity incidence, research on the proximate mecha-
nisms by which reproductive hormones influence tolerance 
mechanisms and autoimmune disease symptoms would benefit from an 
evolutionary medicine framework. A key part of this approach is rec-
ognising the diversity in sex hormone levels and immunomodulation in 
response to ecological pressures, and the effect these interactions might 
have on the immune system of women according to their reproductive 
life stage and energy balance [122,153]. 
To fully understand how this diversity in sex hormone profiles can 
contribute to differences in autoimmune disease incidence, there is also 
a need for more immunological research to take place outside of (post-) 
industrialised, affluent settings that are more reflective of the energetic 
conditions and challenges encountered in our ancestral environment 
[133]. This is necessary to understand how novel changes in energy 
balance and lifestyle might affect autoimmune disease development. For 
example, considering that throughout most of our evolutionary history 
women engaged in prolonged periods of breastfeeding [30], there is a 
severe lack of studies that consider the effect of lactation on the mother’s 
immune profile and consequent autoimmune disease risk. In Tsimane 
women, lactational amenorrhea lasts 12–14 months, and after just 7–9 
months of regular cycling women may get pregnant again [132]. Pre-
liminary studies suggest that during lactation Tsimane women have an 
immune profile that is quite distinct from both normal cycling and 
pregnant women [154]. Yet, it is not properly known how breastfeeding 
duration influences tolerance mechanisms in women and subsequent 
autoimmune disease risk. 
Although methodologically challenging, future research on autoim-
mune diseases should particularly focus on understanding possible 
variation in epigenetic regulation of the AIRE gene in response to 
ecological pressures and differences in oestradiol levels. Additionally, 
the effect of pregnancy on mechanisms of central tolerance deserves 
further attention. Research is also needed on the variation in cyclical 
immunity in relation to autoimmune disease incidence and symptom-
atology, specifically looking at fluctuations in Treg/Th17 and inflam-
matory cytokine ratios across the menstrual cycle in different ecological 
settings, and the influence in lifetime menstrual cycles on Treg-pool and 
peripheral tolerance. For this purpose, it is crucial that a more flexible, 
context dependent approach to immunological research is created based 
on life history theory and evolutionary principles. This is needed to 
enhance our understanding of how variations in ovarian hormone levels 
during different reproductive stages contribute to population level dif-
ferences in autoimmune disease incidence. Currently no accounts of 
autoimmune disease exists in subsistence populations, although this 
cannot be taken as prove of absence of incidence of these diseases 
outside of (post-)industrialised, affluent contexts, as it is highly likely 
that under-diagnosis and under-reporting of autoimmune disease 
symptoms are responsible for the absence of such accounts. Due to their 
low life expectancy at birth, which is skewed because of infant mortality, 
it is a common misconception to assume that individuals from subsis-
tence populations may not live long enough to experience chronic dis-
eases associated with ageing [142], such as autoimmune disorders. 
However, the modal age of death of adults in hunter-gathers is 68–78 
years [142–143] and there are many autoimmune diseases whose onset 
is most frequent at earlier stages of life [10]. Immunological research 
will benefit from considering the reasons for differences in autoimmune 
disease incidence in ecologically diverse populations, taking into ac-
count evolutionary explanations for variation in sex hormones, immu-
nomodulation, and tolerance mechanisms. As reproductive function 
affects the body beyond fertility and pregnancy alone, understanding 
interactions between sex hormones and immune system throughout 
women’s reproductive history is indispensable for advancing female 
health. 
Glossary  
Andropause The male equivalent of menopause, characterised by 
a significant drop in androgen production whereas 
oestrogen levels remain more stable. 
Cellular immunity is activated by pro-inflammatory cytokines and 
regulated by Th1 and Th17 cells. The cellular immune 
response offers protection against intracellular 
pathogens such as viruses, as well as fungi and 
extracellular bacteria. 
(continued on next page) 
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(continued ) 
Cytokines regulatory proteins of the immune system. 
Graves disease humoral autoimmune disease of the thyroid which 
involves antibodies against the thyroid stimulating 
hormone (TSH) receptors causing hyperthyroidism. 
Th2 cell mediated autoimmune disease. 
Humoral immunity consists of B-cells and their antibodies and is 
activatedby anti-inflammatory cytokines that cause 
Th2 cell differentiation. The main purpose of humoral 
immunity is to fight of extracellular parasites. 
Immunomodulation the modification of the responses or functioning of the 
immune system, either by activating or by supressing 
certain features of the immune response. 
Life history theory Life-history theory is a framework in biology that 
explains this phenotypic plasticity by predicting that, 
in face of constraints on the amount of resources 
available throughout an organism’s lifespan, 
compromises in energetic investment into vital 
physiological functions are inevitable. Consequently, 
organisms optimise fitness by interacting with 
environmental conditions through trade-offs between 
growth, reproduction, and somatic maintenance, 
including immunity. 
Mismatch an evolutionary mismatch perspective suggests that 
our environment is changing more rapidly than we 
can adapt to and that there is a dyscongruence 
between the rate at which our bodies evolve and our 
rapidly changing environments and lifestyles. 
Multiple sclerosis (MS) chronic, inflammatory autoimmune disease affecting 
myelin in the central nervous system. This is a Th1/ 
Th17 cell mediated autoimmune disease. 
Nulliparity A medical term for describing a woman who has 
never carried a pregnancy or given birth to a child. 
Proximate mechanisms according to Tinbergen’s four questions in biology 
(1963) proximate mechanisms what the immediate 
cause is for a certain biological phenomenon. By 
asking ‘how’ questions immunological research helps 
us understand immediate causes of pathology but 
might neglect bigger questions, such as why 
vulnerabilities to certain pathologies arose to start 
with. These latter type of question is the domain of 
‘ultimate explanations’. 
Rheumatoid arthritis (RA) chronic, inflammatory autoimmune disease, which is 
relapsing but progressive and mainly affects the 
bones and cartilage. Th1/Th17 cell mediated 
autoimmune disease. 
Semi-allogeneic sharing some but not all genes with the mother since 
foetus inherits half of its genes from the father. 
Systemic lupus 
erythematosus (SLE) 
humoral autoimmune disease involving B cell 
hyperactivity and autoantibody production against 
nuclear antigens. This causes an inflammatory 
rheumatic disease involving multiple organ systems. 
Th2 cell mediated autoimmune disease. 
Th1 cells T-helper cells type 1 are important in the cellular 
immune response. The inflammatory cytokines they 
secrete stimulate macrophages but most importantly 
also cytotoxic-T-cells. Thus Th-1 cells are important 
in regulating responses to intracellular pathogens. 
However Th1 cells also play a role in cellular- 
mediated autoimmune diseases such as MS. 
Th17 cells T-helper cells type 17 are part of the cellular immune 
response. They secrete inflammatory cytokines and 
are important in the response to extracellular bacteria 
and fungi. They play a pathogenic role in 
inflammatory, cellular-mediated immune responses 
such as MS. 
Th2 cells T-helper cells type 2 are important in the humoral 
immune response. Th2 cells secrete anti- 
inflammatory cytokines which regulate the humoral 
immune response.Autoreactive Th2 cells are 
pathogenic in Th2 type autoimmune diseases such as 
SLE. 
Tolerance also known as immunotolerance, this is a state of 
unresponsiveness of the immune system to antigens 
derived of the own tissues that may have the capacity 
to elicit an adaptive immune response. 
Tregs T-regulatory cells’ main function is the suppression 
and regulation of immune responses as well as 
(continued on next column)  
(continued ) 
tolerance. They also play an important role during 
pregnancy in the tolerance to a semi-allogeneic 
foetus. There are two types of Tregs, those that are 
centrally induced and those that originate in the 
periphery. 
Type 1 diabetes autoimmune disease causing the progressive loss of 
insulin-secreting cells pancreatic islets. Cellular 
autoimmune diseases with an occasional humoral 
component, especially in children. 
Ultimate explanations according to Tinbergen’s four questions in biology 
(1963), ultimate explanations ask for the function and 
phylogeny of a trait or complex biological 
phenomenon. Ultimate explanations are guiding 
evolutionary anthropology/biology research and ask 
‘what for’ rather than ‘how’. For example, one may 
ask “how did natural selection leave our body 
vulnerable to developing autoimmune disease? 
Unopposed oestrogen levels during the menopausal transition, progesterone levels 
decline nearly a decade before oestradiol levels 
rapidly fall six months before menopause (age 49-51). 
WEIRD the acronym for Westernised, Educated 
Industrialised, Rich, and Democratic was introduced 
by Henrich and colleagues in 2010 to describe the 
unusual psychological characteristics of people living 
in such societies. The term is now increasingly also 
applied to describe the abnormal physiological 
features people living in these societies exhibit.  
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reproduction and health: an evolutionary perspective. The Lancet [Internet]. 
2017;390(10093):510–20. Available from: http://linkinghub.elsevier.com/ 
retrieve/pii/S0140673617305731. 
[52] Tsaknaridis L, Spencer L, Culbertson N, Hicks K, LaTocha D, Chou YK, et al. 
Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss 
of suppressive activity. Journal of Neuroscience Research [Internet]. 2003 Oct 15 
[cited 2018 Feb 20];74(2):296–308. Available from: http://doi.wiley.com/ 
10.1002/jnr.10766. 
[53] Proekt I, Miller CN, Lionakis MS, Anderson MS. Insights into immune tolerance 
from AIRE deficiency. Current Opinion in Immunology [Internet]. 2017 [cited 
2018 Feb 22];49:71–8. Available from: doi: 10.1016/j.coi.2017.10.003. 
S.M. Keestra et al.                                                                                                                                                                                                                              
Medical Hypotheses 151 (2021) 110558
13
[54] Dragin N, Bismuth J, Cizeron-Clairac G, Biferi MG, Berthault C, Serraf A, et al. 
Estrogen-mediated downregulation of AIRE influences sexual dimorphism in 
autoimmune diseases. J Clin Investig 2016;126(4):1525–37. 
[55] Matsumoto M, Matsumoto M, Tsuneyama K, Kinashi T, Mouri Y, Ueda Y, et al. 
Mode of Tolerance Induction and Requirement for Aire Are Governed by the Cell 
Types That Express Self-Antigen and Those That Present Antigen. The Journal of 
Immunology [Internet]. 2017 [cited 2018 Apr 17];199(2):3959–71. Available 
from: http://www.jimmunol.org/content/199/12/3959. 
[56] Torgerson TR. Regulatory T cells in human autoimmune diseases. Springer Semin 
Immun [Internet]. 2006 [cited 2018 Apr 17];28:63–76. Available from: https:// 
link.springer.com/content/pdf/10.1007%2Fs00281-006-0041-4.pdf. 
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